Home
Journal Archives
New manuscripts
Reviewer's Page
Submit Online
Manuscript Guide
Editorial Board
GFCC Board
Associations
Scientific Events
Advertise
Contact Us
 
   
  July 2010 Issue is now available!  
     
 

 

 

Submit your manuscripts!
The next issue of the journal will be published on Jan 2011
 
     
   
  Articles in GJO are  indexed at PubMed/ MedLine database of the U.S. National Library of Medicine.  
     
  Sponsored by:  
   
 

Manuscript Guidelines

 

The aim of the Gulf Journal of Oncology is to provide a forum for the exchange of clinical and scientific information for Oncology community in the Gulf Cooperation Council (GCC) and the Arab world. The Gulf Journal of Oncology (GJO) will be of primary interest to doctors practicing in the field of Oncology. The GJO also publishes in-depth reviews and articles related to Oncology. Preference will be given to oncological issues in the Gulf and Arab World.

  Submit manuscripts:

1. By Mail/Post

The Gulf Federation for Cancer Control
P.O. Box 26733, Safat 13128, State of Kuwait
Dr. Khaled Al-Saleh, General Secretary and
Editor-in-Chief, GJO
Tel. : +965-22530186 /22530184
Fax : +965-22510137

2. Online in the journal's website (preferred)

3. By email to gffccku@yahoo.com

 

General Instructions

bullet

When submitting your manuscript for publication in our journal, it should be accompanied by a letter clearly stating that your manuscript was not previously published in any other journal and/or under consideration for publication in the future. In case the paper has been previously published, a letter of acceptance from the relevant journal editor should be attached with your manuscript;

bullet

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee, and therefore, have been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. No details that might disclose the identify of the subject’s under study should be mentioned. A patient must not be recognizable in photographs unless a written consent of the subject has been obtained;

bullet

A table or illustration that is published elsewhere should be accompanied by a reproducibility statement from the authors and publishers;

bullet

Reports on animal experiments must state that the “Principle of laboratory animal care” were followed. The editors reserve the right to reject manuscripts that do not comply with the above requirements;

bullet

The author will be held responsible for false statements;

bullet

A digital copy of the manuscript should be submitted on a compact disc (CD) or attached online or by email. The preferred file format is Microsoft Word®. Do not use indentations. Enter your text continuously flush left. Arrange headings flush left. Insert only one space after punctuation marks. Store illustrations as separate files and do not integrate them in your text. The text should be double spaced, with wide margins on one side of the paper only, and should be carefully prepared in the style of this Journal and reviewed before submission. Pages should be consecutively numbered, starting with the title page. The desired position of figures and tables should be marked in the document.

  Short-Communications

Short communications represent a vehicle for rapidly disseminated novel ideas of great interest to the Oncology community, ideas which have not yet been extensively explored in a large clinical trial. Innovative work on machines, instruments, applicators, etc is most welcome. Short communications should contain a maximum of 1200 – 1500 words and no more than 6 tables and/or figures, in whatever combination. Tables and/or figures, should be prepared with appropriate, clear labels in a format of 8.6 x 8cm. References should be confined to 20. Short communications should clearly state the aim of the study, materials, methods and patients, results, a brief discussion and a conclusion. Titles should be to the points and concise.

  Preparation of Manuscript

Manuscript should be accompanied by a formal letter of request for publication which should be signed by the authors. The speed of publication depends greatly upon following these guidelines precisely.

The manuscript should be divided clearly into an Introduction, Materials & Methods, Results, Discussion and References. The Text should be concise and consistent as to spelling, abbreviation etc. They are most often subdivided into:

bullet

Title Page

bullet

Abstract

bullet

Introduction (Not Headed)

bullet

Methods

bullet

Results

bullet

Discussion

bullet

List of References

bullet

Acknowledgements

bullet

Tables

bullet

Illustrations

Title Page
This page should be a separate page, including the name(s), degree and address(es) of author(s). It should be made clear which address relates to which authors. A short running title containing not more then 50 characters and spacing should be included. The title page should be paginated as page 1 of the paper. To facilitate communication between the Authors, Editors and Publisher, the author should furnish a fax number and/or e-mail address on the title page of the manuscript.

Abstract
Should be a summary of the Hypothesis or Aims of the work, the basic material and method and the conclusion of the study. The abstract should be normally of 150 – 250 words. Immediately following the abstract, up to five relevant Key Words should be supplied for subject indexing.

Introduction
The introduction should give a concise account of the background of problem and the objective of the investigation. Previous work should be quoted only if it has a bearing on the present problem.

Methods
Methods must be described in sufficient detail to allow the investigation to be interpreted and repeated by the readers. If the methods are commonly used, only a reference to the original source is required. Any modification of previously published methods should be described and reference given. When a drug is first mentioned it should be given the generic or official name, followed in parentheses by chemical formula only if the structure is not well known.

Results
Description of results, should be concise and permit repetition of the investigation by others, data should not be repeated unnecessarily in text, table and figures. Significance should be given as values of probability. The desired positions of tables and figures may be indicated by written instructions enclosed within lines and brackets, for example : [TABLE 2] near the paragraph

Discussion
The discussion should not merely repeat or recapitulate the results, but it should present their interpretation against the background of existing knowledge. It should include a statement of any assumptions on which conclusions are based. Disclosure of any financial support should be clearly mentioned in the text with their source.

Acknowledgements
Acknowledgement will be printed in small type. They should be brief and should include reference to sources of support and sources of drugs not freely available commercially. Individuals named must be given the opportunity to read the paper an approve their inclusion in the acknowledgements.

References

bullet

References should commence on a new page.

bullet

References must be numbered consecutively in the text by the order in which they are first mentioned in the text.

bullet

References in text, tables and legends should be identified by Arabic numbers appearing in the text in brackets and subscripted. eg. list (3).

bullet

The names and initials of all authors should be listed.

bullet

Journals listed should be abbreviated according to the indêx Medicus format.

bullet

The number of references should preferably not exceed 30-40 for review paper, 20-30 for original articles and 10-15 references for case reports.

Examples of correct forms of references:

Example 1. Journal (Three Authors should be listed before using et al)
Merrick GS, Buter WM, Dorsey AT, el al. Seed visibility in the prostatic and periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 2000;46:215-220.

Example 2. Chapter in a book
Holl DF. Morphine in malignant pain. In: Smith F, Covino DM, eds, Acute pain. London: Butterworth’s, 1990; 200 – 210.

Example 3. Monographs
Tito BD, Regional block, 5th Edn. Springfield, Madison Charles D. Thomas, 1989.

Tables
Tables must supplement, not duplicate, information in the text itself and be explanatory. Each table should have a title (max. 5 words) and to be submitted on a separate sheet or file. Whenever there is referral to a table or a figure at the end of a sentence, the table should be between square bracket. e.g. [Table 2] and the figure between bracket e.g. (Fig. 4). No brackets or square to be used when referral is within the sentence.

Illustrations
Line drawings, graphs and charts should be submitted using Microsoft Word, Excel or Powerpoint format. Pictures or graphic files should have a resolution of at least 800 x 600 and saved as JPEG or Bitmap files.

 

   
   
 

    Site managed by Mike.Bautista
    All rights reserved. Copyright © 2010